Related stories
Ionis Cuts Key Drug Revenue Outlook by 50%; Shares Fall 19%
Ionis Pharmaceuticals cut revenue guidance for a key therapy due to sluggish sales. Shares fell 19% to $32.09 in premarket trading Monday.
M impact | EARNINGS | Nov 09, 2026, 01:12 PM UTC
Motorcar Parts of America Reports Q2 Sales of $169.2 Million
Reuters reports Q2 EPS of $0.07.
M impact | EARNINGS | Nov 09, 2026, 01:11 PM UTC
Global Ship Lease Reports Third-Quarter EPS of $2.75
M impact | EARNINGS | Nov 09, 2026, 01:11 PM UTC
AI chip financing hits a wall
After rushing to lend money for the data-center buildout, now some investors can’t dump it fast enough, including whole portfolios of loans that are being shopped at steep discount
H impact | EARNINGS | Nov 09, 2026, 01:09 PM UTC
Lincoln Educational Sees 2026 EPS Guidance
L impact | EARNINGS | Nov 09, 2026, 01:07 PM UTC
SharpLink Gaming Reports Q3 EPS of USD 3.45
SharpLink Gaming reported Q3 net income of USD 751.4 million.
M impact | EARNINGS | Nov 09, 2026, 01:01 PM UTC